SAN FRANCISCO, Feb. 24, 2020 /PRNewswire/ -- The deep brain
stimulation devices market is anticipated to achieve USD 1225.44 million by 2022 on account of rising
aging populace across the globe that further leads to risk of
neurological disorders. Deep brain stimulation (DBS) is a device of
neurostimulation that comprises the activation of brain neurons
using electric stimulation. The device sends electrical impulses
using electrodes attached to specific targets in the brain nuclei
for the treatment of neuropsychiatric disorders. Rising cases of
essential tremors, epilepsy, and Parkinson's and Alzheimer's
disorders across the globe will stimulate product demand in the
forecast period. Technological enhancements such as integrated
pulse generators, customized programming, and robot-assisted
implantations will boost product demand in the near future. For
instance, the U.S. Food and Drug Administration (FDA) allowed
launching of Boston Scientific Corporation's Vercise Deep Brain
Stimulation (DBS) System, which is exclusively used to treat signs
of Parkinson's disease.
Factors such as the high investment cost particularly for
enhanced DBS devices and high risk of infection at the stimulator
site will hamper overall industry growth. Rising awareness among
populace and expansion of healthcare sector in emerging economies
such as India, Indonesia, and Malaysia will create new growth opportunities
in the coming years. Deep brain stimulation devices industry is
categorized based on product type, applications, and region. Based
on product type, the industry is categorized into dual-channel DBS
and single-channel DBS. Based on applications, the deep brain
stimulation devices industry is categorized into Dystonia,
Parkinson's disease, essential tremor, and others. Parkinson's
disease segment is expected to account for the largest revenue
share and continue its dominance over the forecast period. It is a
neurodegenerative disease with minimum treatment alternatives.
Thus, long-term investment associated with treatment and
medications for Parkinson's disorder will rise the adoption of DBS
in the forecast period. For instance, as per the report published
by International Journal of Neurology and Neurotherapy states that
requirement of medicines is abridged by over 50% within 6 months of
DBS treatment.
Geographically, the deep brain stimulation devices market is
categorized into Middle East and
Africa, Asia Pacific, South
America, North America, and
Europe. Globally, North America is projected to remain dominant
over the forecast period. The high growth is attributable to rising
adoption of enhanced technology and increasing occurrence of
psychiatric disorders along with rising geriatric populace in the
region. Countries such as the U.S. and Canada are major consumers and led the overall
industry in this region. For instance, as per the research report
by Anxiety and Depression Association of America, over 18% of the
U.S. populace is suffering from a neurological disorder. Thus, will
raise the demand for brain stimulation devices in the coming years.
Asia Pacific is anticipated to
witness the fastest growth rate of deep brain stimulation devices
over the forecast period on account of rising investments in
R&D activities by key manufacturers and increasing preference
for clinical trials. In addition, increasing occurrence of
neurodegenerative disorders along with high demand for long-term
and effective treatment solutions will show a positive impact on
overall industry growth in the coming years.
Download PDF to know more details about "Deep
Brain Stimulation Devices Market" report 2026.
Prominent players of the deep brain stimulation devices market
include SceneRay, Medtronic, Beijing Pins, Boston Scientific, and
St Jude Medical. These players are concentrating on R&D
activities and are accepting new business expansion strategies like
collaboration and union, novel drug launch, and acquisitions to
mark their footprint in the industry. Also, these producers are
focusing on enhancements in overall health outcomes. This, in turn,
will raise the industrial revenue share in the near future.
In this report, global Deep Brain Stimulation Devices Market
2019 by Manufacturers, Regions, Type and Application, forecast to
2025 offers a comprehensive theory of the global Deep Brain
Stimulation Devices market. The report evaluates the present and
future market opportunities in the market. The report presents a
comparative assessment of the market. It highlights a number of the
main drivers and restraints factors influencing the expansion of
the market. Then in this report, key trends and segmentation
analysis, and all the regions are coated. It comprises historical
data, significance, statistical data, size & share, market
analysis by product and market trends by key players, and market
price & demand. The market is separated by product sort,
application, and countries. In the last several years, global
market of Deep Brain Stimulation Devices developed rapidly, with an
average growth rate of 11.8 %. In 2016, global revenue of Deep
Brain Stimulation Devices is nearly 720
million USD; the actual production is about 30900 units.
Deep brain stimulation (DBS) is a neurosurgical procedure
involving the implantation of a medical device called a
neurostimulator (sometimes referred to as a 'brain pacemaker'),
which sends electrical impulses, through implanted electrodes, to
specific targets in the brain (brain nuclei) for the treatment of
movement and neuropsychiatric disorders. DBS in select brain
regions has provided therapeutic benefits for
otherwise-treatment-resistant disorders such as Parkinson's
disease, essential tremor, dystonia, chronic pain, major depression
and obsessive-compulsive disorder (OCD). Despite the long history
of DBS, its underlying principles and mechanisms are still not
clear. DBS directly changes brain activity in a controlled manner,
its effects are reversible (unlike those of lesioning techniques),
and it is one of only a few neurosurgical methods that allow
blinded studies. Global Deep brain stimulation (DBS) Market will
reach 769.49 Million USD by the end
of 2017, and the revenue in 2022 will be 1225.44 Million USD with the CAGR of 12.34%.
North America is the largest
sales place, with a sales market share nearly 51% in 2016.
Following North America,
Europe is the second largest sales
place with the sales market share of 30%. China, Japan
is also important sales regions for Deep Brain Stimulation Devices.
The classification of Deep Brain Stimulation Devices includes
Single-channel DBS and Dual Channel DBS, and the revenue proportion
of Single-channel DBS in 2016 is about 45.2%. Deep Brain
Stimulation Devices can be used for Parkinson's disease, Essential
Tremor, Dystonia and other. The most proportion of Deep Brain
Stimulation Devices is used for Parkinson's disease, and the sales
proportion is about 77.4% in 2016. Increasing prevalence of
neurological disorders is one of the critical factors driving the
growth of this (DBS) deep brain stimulation market globally.
Access 100 page research report with TOC on "Deep Brain
Stimulation Devices Market" available with Radiant Insights, Inc.
@
https://www.radiantinsights.com/research/global-deep-brain-stimulation-devices-market-insights-and-forecast-to-2026-by-top-companies
Deep Brain Stimulation Device market is mainly occupied by large
companies, Sorin as the largest player in the market produced over
57% of Artificial Heart Lung Machine and made more than 59.6% of
revenue share in 2016. MAQUET followed as second produced about
18.3% in 2016.
Market Segmentation:
- Geographically, this report is segmented into several key
Regions, with production, consumption, revenue (M USD), market
share and growth rate of Deep Brain Stimulation Devices in these
regions, from 2014 to 2026 (forecast), covering
-
- Asia-Pacific (China, Japan,
Korea, India and Southeast Asia)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- South America (Brazil, Argentina, Columbia)
- Middle East and Africa (Saudi
Arabia, UAE, Egypt,
Nigeria and South Africa)
- Global Deep Brain Stimulation Devices market competition by
top manufacturers, with production, price, revenue (value) and
market share for each manufacturer; the top players
including
-
- Medtronic
- Boston Scientific
- St Jude Medical
- Beijing Pins
- SceneRay
- On the basis of product, this report displays the
production, revenue, price, market share and growth rate of each
type, primarily split into
-
- Single-channelDBS
- DualChannelDBS
- On the basis on the end users/applications, this report
focuses on the status and outlook for major applications/end users,
consumption (sales), market share and growth rate of Deep Brain
Stimulation Devices for each application, including
-
- Parkinson's disease
- EssentialTremor
- Dystonia
- Others
Browse reports of similar category available with Radiant
Insights, Inc.:
- Medical Device Outsourcing Market
- Medical Device Testing Services Market
- Wearable Medical Device Market
- Dermatology Devices Market
About Radiant Insights, Inc.:
At Radiant Insights, we work with the aim to reach the highest
levels of customer satisfaction. Our representatives strive to
understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact:
Michelle Thoras.
Corporate Sales Specialist
Radiant Insights, Inc.
Phone: +1-415-349-0054
Toll Free: 1-888-928-9744
Email: sales@radiantinsights.com
Web: https://www.radiantinsights.com/
Blog: https://radiantinsightsinc.blogspot.com/